Precision Business Insights has published a report on the global oral thin film drugs market, estimating its value at USD 3,173.3 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 9.7% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/oral-thin-film-drugs-market
Market Definition:
Thin Film Oral Drugs are a contemporary method of drug delivery in which the treatment is embedded in a thin, dissolveable polymer film that is applied within the mouth, usually against the cheek (buccal) or on the tongue (sublingual). Because these films dissolve rapidly, the medication can pass past the mouth mucosa and enter the bloodstream.
Drivers:
1) Expansion of OTC and e-commerce.
2) Adoption of solvent casting and printing technologies.
The global oral thin film drugs market segmentation:
1) By Product: Fast Dissolving Buccal Film, Sublingual Film.
2) By Application: Anti-Emetic, Opioid Dependence, Schizophrenia, Anti-Migraine, Dietary Supplements, Mouth Freshener, Sedative & Hypnotic, Anti-Flatulent, Smoking Cessation, Vitamin D3 Supplements, Anti-Allergic/Nasal Decongestion, Others.
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Drug Stores, Others.
Regional Overview:
The report also examines the current concerns and their Future Effects on the oral thin film drugs market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the oral thin film drugs market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
· North America (U.S., Canada)
· Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
· Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
· Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
· Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like ZIM Laboratories Limited, IntelGenx Corp. Indivior plc, Adhex Pharma, MonoSol Rx, CURE Pharmaceutical, Wolters Kluwer, Pfizer, Inc., Novartis AG, LTS Lohmann Therapie-Systeme AG, GlaxoSmithKline Plc, Solvay, Allergan plc.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian